Search

Boehringer Ingelheim Empowers 380 Regional Experts with Latest Insights in Cardio-Renal-Metabolic Care

Boehringer Ingelheim hosted the ‘CRM 360 standalone meeting’, ‘IMETA CRM Discussions for EXperts (MEDEX)’, to discuss the latest advances in the management of cardio-renal-metabolic conditions

Boehringer Ingelheim unites dermatologists to discuss the management of Generalized Pustular Psoriasis (GPP)

The ‘GPP Summit, discussed latest research and advances in the management of GPP to help improve patient outcomes across Saudi Arabia, and the United Arab Emirates.

About Office Hours

Boehringer Ingelheim Office Hours mentors early-stage life-science companies providing access to expertise, an industry perspective and feedback.

Boehringer Ingelheim announces Reach Africa Access Healthcare programs outcomes

Boehringer Ingelheim, announces “In Reach Africa” Access to Healthcare programs outcomes

Boehringer Ingelheim Breaks Guinness World Records™ title In Solidarity with Rare Disease

Boehringer Ingelheim Breaks Guinness World Records™ title In Solidarity with Rare Disease Patients Around the World

Boehringer Ingelheim Raises Ranking by Two Positions in Access-To-Medicine Index for 2021

Mutual benefit: Patient-centricity in clinical trials

Uli Broedl and Bronwyn Lewis share what they learnt from a successful patient organization collaboration on clinical trial design.

Patient Voices...Ian's Story

test

Global poultry trends Professor David Hughes

Professor David Hughes takes us through megatrends in poultry.

2019 performance: stronger foundation to absorb global effects of COVID-19 pandemic

Human Health

Boehringer Ingelheim launches the First Approved Treatment for Idiopathic Pulmonary Fibrosis in Algeria

Nintedanib is the only treatment for Idiopathic Pulmonary Fibrosis approved by the Algerian Ministry of Health

Vaccines

Horses

Elevating Cardio-Renal-Metabolic Care: Boehringer Ingelheim Imparts Latest Insights to 400 Regional Experts

Boehringer Ingelheim hosted the ‘CRM Summit’ to facilitate exchanges and discussions on the latest advances in the management of cardiovascular, renal, and metabolic diseases to help improve patient outcomes across India, the Middle East and Africa

Our Contribution

Humanity is facing serious challenges. We believe we can always do more – for ourselves and for the generations to come.

Leading Science in Oncology

As the oncology community learns more about the complexity of tumor biology, we are discovering new and exciting therapeutic opportunities.

COVID-19: Boehringer Ingelheim steps up effort with Global Support Program

Focus on Alliance Management

Stefan Walke, Global Head of Alliance Management, shares his perspectives on Alliance Management and its contribution to the development of successful long-term partnerships.

Living with type 2 diabetes

People living with type 2 diabetes often suffer a degree of stigma. Learn from Jurjen de Lange what it takes to live a good life despite the disease.

Boehringer Ingelheim Teams Up with the Lebanese Pulmonary Society (LPS) in its Fight against COVID-19

Reggie the Red Blood Cell

Join Reggie, our curious red blood cell, on a journey exploring connections between the heart, kidneys and pancreas.

Science Stories

Lead with Pride – for the Benefit of All.

How Inclusive Leadership advocates for Acceptance and creating a Sense of Belonging

Boehringer Ingelheim sees positive business momentum in 2020 despite impact of COVID-19

About Us

Human Health

Animal Health

Science & Innovation

Partnering

Search

Boehringer Ingelheim Empowers 380 Regional Experts with Latest Insights in Cardio-Renal-Metabolic Care

Boehringer Ingelheim unites dermatologists to discuss the management of Generalized Pustular Psoriasis (GPP)

About Office Hours

Boehringer Ingelheim announces Reach Africa Access Healthcare programs outcomes

Boehringer Ingelheim Breaks Guinness World Records™ title In Solidarity with Rare Disease

Boehringer Ingelheim Raises Ranking by Two Positions in Access-To-Medicine Index for 2021

Mutual benefit: Patient-centricity in clinical trials

Patient Voices...Ian's Story

Global poultry trends Professor David Hughes

2019 performance: stronger foundation to absorb global effects of COVID-19 pandemic

Human Health

Boehringer Ingelheim launches the First Approved Treatment for Idiopathic Pulmonary Fibrosis in Algeria

Vaccines

Horses

Elevating Cardio-Renal-Metabolic Care: Boehringer Ingelheim Imparts Latest Insights to 400 Regional Experts

Our Contribution

Leading Science in Oncology

COVID-19: Boehringer Ingelheim steps up effort with Global Support Program

Focus on Alliance Management

Living with type 2 diabetes

Boehringer Ingelheim Teams Up with the Lebanese Pulmonary Society (LPS) in its Fight against COVID-19

Reggie the Red Blood Cell

Science Stories

Lead with Pride – for the Benefit of All.

Boehringer Ingelheim sees positive business momentum in 2020 despite impact of COVID-19